[Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report].
Identifieur interne : 000830 ( Main/Exploration ); précédent : 000829; suivant : 000831[Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report].
Auteurs : L. Ordo Ez-Boschetti [Mexique] ; C M Torres-Romero [Mexique] ; M J Ortiz De Leo [Mexique]Source :
- Neurologia (Barcelona, Spain) [ 1578-1968 ]
Descripteurs français
- KwdFr :
- MESH :
- usage thérapeutique : Azithromycine, Céfuroxime, Hydroxychloroquine.
- virologie : Confusion, Dyspnée, Leucoencéphalopathie postérieure.
- Adulte d'âge moyen, Humains, Mâle, Pandémies, Tomographie.
English descriptors
- KwdEn :
- Azithromycin (therapeutic use), COVID-19 (diagnosis), COVID-19 (drug therapy), COVID-19 (physiopathology), Cefuroxime (therapeutic use), Confusion (virology), Dyspnea (virology), Humans (MeSH), Hydroxychloroquine (therapeutic use), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Posterior Leukoencephalopathy Syndrome (virology), SARS-CoV-2 (drug effects), Tomography (MeSH).
- MESH :
- chemical , therapeutic use : Azithromycin, Cefuroxime, Hydroxychloroquine.
- diagnosis : COVID-19.
- drug effects : SARS-CoV-2.
- drug therapy : COVID-19.
- physiopathology : COVID-19.
- virology : Confusion, Dyspnea, Posterior Leukoencephalopathy Syndrome.
- Humans, Male, Middle Aged, Pandemics, Tomography.
DOI: 10.1016/j.nrl.2020.08.001
PubMed: 32896464
PubMed Central: PMC7416704
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report].</title>
<author><name sortKey="Ordo Ez Boschetti, L" sort="Ordo Ez Boschetti, L" uniqKey="Ordo Ez Boschetti L" first="L" last="Ordo Ez-Boschetti">L. Ordo Ez-Boschetti</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Neurología, Hospital Español, Ciudad de México, México. Electronic address: neuro20nov@gmail.com.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Mexique</country>
<wicri:regionArea>Departamento de Neurología, Hospital Español, Ciudad de México</wicri:regionArea>
<wicri:noRegion>Ciudad de México</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Torres Romero, C M" sort="Torres Romero, C M" uniqKey="Torres Romero C" first="C M" last="Torres-Romero">C M Torres-Romero</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Neurología, Centro Médico Nacional 20 de Noviembre, Ciudad de México, México.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Mexique</country>
<wicri:regionArea>Departamento de Neurología, Centro Médico Nacional 20 de Noviembre, Ciudad de México</wicri:regionArea>
<wicri:noRegion>Ciudad de México</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ortiz De Leo, M J" sort="Ortiz De Leo, M J" uniqKey="Ortiz De Leo M" first="M J" last="Ortiz De Leo">M J Ortiz De Leo</name>
<affiliation wicri:level="1"><nlm:affiliation>Universidad Veracruzana, Facultad de Medicina Miguel Alemán Valdés, Veracruz, México.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Mexique</country>
<wicri:regionArea>Universidad Veracruzana, Facultad de Medicina Miguel Alemán Valdés, Veracruz</wicri:regionArea>
<wicri:noRegion>Veracruz</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020 Nov - Dec</date>
<idno type="RBID">pubmed:32896464</idno>
<idno type="pmid">32896464</idno>
<idno type="doi">10.1016/j.nrl.2020.08.001</idno>
<idno type="pmc">PMC7416704</idno>
<idno type="wicri:Area/Main/Corpus">000C70</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C70</idno>
<idno type="wicri:Area/Main/Curation">000C70</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C70</idno>
<idno type="wicri:Area/Main/Exploration">000C70</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report].</title>
<author><name sortKey="Ordo Ez Boschetti, L" sort="Ordo Ez Boschetti, L" uniqKey="Ordo Ez Boschetti L" first="L" last="Ordo Ez-Boschetti">L. Ordo Ez-Boschetti</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Neurología, Hospital Español, Ciudad de México, México. Electronic address: neuro20nov@gmail.com.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Mexique</country>
<wicri:regionArea>Departamento de Neurología, Hospital Español, Ciudad de México</wicri:regionArea>
<wicri:noRegion>Ciudad de México</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Torres Romero, C M" sort="Torres Romero, C M" uniqKey="Torres Romero C" first="C M" last="Torres-Romero">C M Torres-Romero</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Neurología, Centro Médico Nacional 20 de Noviembre, Ciudad de México, México.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Mexique</country>
<wicri:regionArea>Departamento de Neurología, Centro Médico Nacional 20 de Noviembre, Ciudad de México</wicri:regionArea>
<wicri:noRegion>Ciudad de México</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ortiz De Leo, M J" sort="Ortiz De Leo, M J" uniqKey="Ortiz De Leo M" first="M J" last="Ortiz De Leo">M J Ortiz De Leo</name>
<affiliation wicri:level="1"><nlm:affiliation>Universidad Veracruzana, Facultad de Medicina Miguel Alemán Valdés, Veracruz, México.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">Mexique</country>
<wicri:regionArea>Universidad Veracruzana, Facultad de Medicina Miguel Alemán Valdés, Veracruz</wicri:regionArea>
<wicri:noRegion>Veracruz</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Neurologia (Barcelona, Spain)</title>
<idno type="eISSN">1578-1968</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (therapeutic use)</term>
<term>COVID-19 (diagnosis)</term>
<term>COVID-19 (drug therapy)</term>
<term>COVID-19 (physiopathology)</term>
<term>Cefuroxime (therapeutic use)</term>
<term>Confusion (virology)</term>
<term>Dyspnea (virology)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Posterior Leukoencephalopathy Syndrome (virology)</term>
<term>SARS-CoV-2 (drug effects)</term>
<term>Tomography (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Confusion (virologie)</term>
<term>Céfuroxime (usage thérapeutique)</term>
<term>Dyspnée (virologie)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Leucoencéphalopathie postérieure (virologie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Tomographie (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Azithromycin</term>
<term>Cefuroxime</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Azithromycine</term>
<term>Céfuroxime</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Confusion</term>
<term>Dyspnée</term>
<term>Leucoencéphalopathie postérieure</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Confusion</term>
<term>Dyspnea</term>
<term>Posterior Leukoencephalopathy Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Tomography</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Tomographie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32896464</PMID>
<DateCompleted><Year>2021</Year>
<Month>01</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1968</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>35</Volume>
<Issue>9</Issue>
<PubDate><MedlineDate>2020 Nov - Dec</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Neurologia (Barcelona, Spain)</Title>
<ISOAbbreviation>Neurologia</ISOAbbreviation>
</Journal>
<ArticleTitle>[Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report].</ArticleTitle>
<Pagination><MedlinePgn>696-698</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0213-4853(20)30263-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nrl.2020.08.001</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ordoñez-Boschetti</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Departamento de Neurología, Hospital Español, Ciudad de México, México. Electronic address: neuro20nov@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Torres-Romero</LastName>
<ForeName>C M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo><Affiliation>Departamento de Neurología, Centro Médico Nacional 20 de Noviembre, Ciudad de México, México.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ortiz de Leo</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
<AffiliationInfo><Affiliation>Universidad Veracruzana, Facultad de Medicina Miguel Alemán Valdés, Veracruz, México.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<Language>spa</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<VernacularTitle>Síndrome de encefalopatía posterior reversible (PRES) asociado a SARS-CoV-2. Reporte de caso.</VernacularTitle>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>08</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Spain</Country>
<MedlineTA>Neurologia</MedlineTA>
<NlmUniqueID>9005460</NlmUniqueID>
<ISSNLinking>0213-4853</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>O1R9FJ93ED</RegistryNumber>
<NameOfSubstance UI="D002444">Cefuroxime</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002444" MajorTopicYN="N">Cefuroxime</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003221" MajorTopicYN="N">Confusion</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054038" MajorTopicYN="N">Posterior Leukoencephalopathy Syndrome</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014054" MajorTopicYN="N">Tomography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>08</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>08</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>1</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>8</Day>
<Hour>8</Hour>
<Minute>47</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32896464</ArticleId>
<ArticleId IdType="pii">S0213-4853(20)30263-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.nrl.2020.08.001</ArticleId>
<ArticleId IdType="pmc">PMC7416704</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Neurol Sci. 2020 Sep 15;416:117019</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32679347</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurol Sci. 2019 Sep 15;404:72-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31349066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurol Sci. 2020 Jun 15;413:116832</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32299017</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Emerg Med. 2020 Jul;38(7):1549.e3-1549.e7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32425321</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect. 2020 Jun;80(6):607-613</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32283152</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Brain Behav Immun. 2020 Jul;87:18-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32240762</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurol Sci. 2020 Jul 15;414:116943</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32474362</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Neurol Sci. 2020 Jun 15;413:116858</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32387762</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Mexique</li>
</country>
</list>
<tree><country name="Mexique"><noRegion><name sortKey="Ordo Ez Boschetti, L" sort="Ordo Ez Boschetti, L" uniqKey="Ordo Ez Boschetti L" first="L" last="Ordo Ez-Boschetti">L. Ordo Ez-Boschetti</name>
</noRegion>
<name sortKey="Ortiz De Leo, M J" sort="Ortiz De Leo, M J" uniqKey="Ortiz De Leo M" first="M J" last="Ortiz De Leo">M J Ortiz De Leo</name>
<name sortKey="Torres Romero, C M" sort="Torres Romero, C M" uniqKey="Torres Romero C" first="C M" last="Torres-Romero">C M Torres-Romero</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000830 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000830 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32896464 |texte= [Associated posterior reversible encephalopathy syndrome (PRES) to SARS-CoV-2. Case report]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32896464" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
This area was generated with Dilib version V0.6.38. |